Live
- Three persons admitted to hospital for diarrhea treatment
- First Star Outside Milky Way Captured: WOH G64 is 2,000 Times Larger Than the Sun
- Sikkim govt to constitute state Niti Ayog: CM Tamang
- CBI books Rajasthan narcotics inspector for Rs 3 lakh bribe
- Rajasthan bypolls: A tough contest between BJP and Congress
- Albania joins SEPA, paving way for EU integration
- Japanese government approves 250-billion USD economic package to ease price pain
- Six pharma companies to set up their units in Telangana
- The Unstable Events of a 17-Wicket Day in Perth: India vs Australia
- Dutch FM's Israel trip cancelled after Netanyahu's arrest warrant
Five more Covid vaccines in pipeline
Five more Covid vaccines in pipeline
Johnson & Johnson, Sputnik V expected by Oct
The Centre is gearing to scale up the Covid-19 vaccine production as more and more States flag shortage of vaccine doses. It is expected that by the end of the third quarter of 2021, India will get five additional vaccine manufacturers apart from current manufactures Covishield and Covaxin.
Around 20 Covid-19 vaccines are in various clinical and pre-clinical stages and will add a boost to India's vaccine production. As per top government sources, the new strategy is to manufacture additional vaccine doses.
"These vaccines are Sputnik V vaccine (in collaboration with Dr Reddy's), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila's vaccine, and Bharat Biotech's intranasal vaccine," a source was quoted as saying. Sputnik V vaccine is expected to get the Emergency Use Approval (EUA) within the next ten days.
